| 注册
首页|期刊导航|中医学报|基于肠道菌群探讨从瘀论治IgA肾病

基于肠道菌群探讨从瘀论治IgA肾病

王晓悦 赵芃博 齐鑫 李佳琦 张垒 任桐

中医学报2024,Vol.39Issue(7):1368-1373,6.
中医学报2024,Vol.39Issue(7):1368-1373,6.DOI:10.16368/j.issn.1674-8999.2024.07.227

基于肠道菌群探讨从瘀论治IgA肾病

Treatment of IgA Nephropathy from Perspective of Stasis Based on Gut Microbiota

王晓悦 1赵芃博 1齐鑫 1李佳琦 1张垒 1任桐1

作者信息

  • 1. 天津中医药大学第一附属医院,天津 300381||国家中医针灸临床医学研究中心,天津 300381
  • 折叠

摘要

Abstract

IgA nephropathy(IgAN)is the most common primary glomerulonephritis disease in China,which is one of the main causes of end-stage renal disease.Blood stasis is the key pathogenesis of the disease progression.Therefore,activating blood circulation and re-solving stasis should be carried out throughout the treatment process.Blood stasis syndrome covers a variety of modern hemodynamic changes.Imbalance of gut microbiota can lead to blood circulation disorders,platelet aggregation,prethrombotic state by affecting hemo-dynamics,inflammatory response and other ways,thus inducing the occurrence and development of IgAN.The application of traditional Chinese medicine for activating blood circulation and resolving stasis can improve the disorder of gut microbiota and delay the progres-sion of IgAN to end-stage renal disease.

关键词

IgA肾病/肠道菌群/从瘀论治/活血化瘀

Key words

IgA nephropathy/gut microbiota/treatment from stasis/activating blood circulation and resolving stasis

分类

中医学

引用本文复制引用

王晓悦,赵芃博,齐鑫,李佳琦,张垒,任桐..基于肠道菌群探讨从瘀论治IgA肾病[J].中医学报,2024,39(7):1368-1373,6.

基金项目

国家自然科学基金项目(81873151) (81873151)

中医学报

OACSTPCD

1674-8999

访问量0
|
下载量0
段落导航相关论文